Answers are grounded in this paper and cite their sources.
Herpes zoster oticus produces facial paralysis with a low recovery rate. Acyclovir, a specific virostatic drug, was given intravenously in five herpes zoster oticus patients, and in three of them was followed by oral therapy. In follow-ups of 1 to 24 months, one patient had grade I recovery, three patients grade II, and one grade III. These good results encourage the use of acyclovir in herpes zoster oticus patients.
No takes yet. Share an insight, caveat, or question.
Uri et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: